PAUL A. LAVIOLETTE - 30 Jun 2021 Form 4 Insider Report for ASENSUS SURGICAL, INC.

Role: Director
Signature: /s/ Joshua Weingard, as attorney-in-fact for Paul A. LaViolette
Issuer symbol: N/A
Transactions as of: 30 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2021, 19:08:46 UTC
Previous filing: 07 May 2021
Next filing: 08 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASXC	Common Stock	Award	$0	+13,846		$0.000000	13,846	01 Jul 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ASXC	Stock Option	Award	$0	+10,025		$0.000000	10,025	30 Jun 2021	Common Stock	10,025	$3.17	Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Registrant's common stock.
F2	Forfeiture restrictions will lapse on the RSUs on the first anniversary of the date of grant, provided that if the date of the 2022 annual meeting of stockholders is earlier, the restrictions will lapse on the date of the annual meeting.
F3	The Reporting Person has assigned shares issued from prior grants of restricted stock units to SV Health Investors in accordance with its operating agreement and is expected to transfer the shares underlying this reported award upon vesting.
F4	Represents an equity award issued under the Registrant's Amended and Restated Incentive Compensation Plan in lieu of an annual cash retainer, paid quarterly in arrears for the quarter ended June 30, 2021.
F5	The award is fully exercisable six months after the grant date, subject to earlier acceleration as approved by the Board of Directors.